Navigation Links
invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
Date:6/25/2012

Pittsburgh, PA (PRWEB) June 25, 2012

invivodata inc. ® the industry leader in reliable electronic solutions and strategic consulting services for successful Clinical Outcome Assessment (COA) data collection in global clinical research, today announced that it’s president and CEO Doug Engfer, has been selected as a finalist for the Ernst & Young Entrepreneur Of The Year Award in the Western Pennsylvania and West Virginia area. The annual awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in areas including innovation, financial performance and personal commitment to their businesses and communities.

Ernst & Young’s Entrepreneur of the Year Award is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. The program is significant because it honors and recognizes men and women who create the products, services and jobs that help our economy and communities grow.

“I’m deeply honored to receive this recognition and consider it a milestone accomplishment for invivodata,” said Doug Engfer. “Our record growth over the past few years is the direct result of our employees’ hard work and commitment to delivering the best COA data for our customers’ clinical development programs.”

About invivodata
invivodata is the only fully-integrated Clinical Outcomes Assessments (COA) company delivering regulatory-proven strategic consulting and practical electronic solutions to biopharmaceutical companies who depend upon patient-centered research. From reliable and scientifically sound consulting that helps research teams effectively develop, execute, and document COA strategies to electronically collecting COA data in global clinical development programs, invivodata helps its customers strategically use patient, clinician, and observer reported outcomes data (PROs, ClinROs & ObsROs) to support labeling claims, enhance reimbursement strategies, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata’s electronic solutions and strategic consulting services have been used in over 600 clinical projects and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata, inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit http://www.invivodata.com

Read the full story at http://www.prweb.com/releases/2012/6/prweb9637042.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Fortis Vice President of Nursing Robert Anders Named Academy of Nursing Education Fellow by National League for Nursing
2. CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
3. RIFM Board Names New President
4. Ultragenyx Appoints Shalini Sharp as Chief Financial Officer and Senior Vice President, Finance
5. Hospira Names John B. Elliot Senior Vice President of Operations
6. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
7. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
8. Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer
9. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
10. Fitzsimons Redevelopment Authority Names New President & CEO
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Kathy Goin is joining ... She brings years of expertise in establishing and leading clinical operations at Sponsors ... licensed occupational therapist, through a variety of leadership roles in Clinical Operations, to ...
(Date:5/22/2017)... , ... May 22, 2017 , ... ... with other leaders of the Maryland Biohealth community in developing and issuing recommendations ... Top 3 U.S. BioHealth Innovation Hub by 2023. , The ...
(Date:5/19/2017)... ... May 19, 2017 , ... The University City Science Center ... ripe for commercialization, and who are affiliated with the 21 partner academic and ... QED, now in its tenth round, is the first multi-institutional proof-of-concept program for ...
(Date:5/18/2017)... ... 17, 2017 , ... DAACRO ... power by providing investigators access to a high-profile scientific advisory board. Today, ... advisory board. “We are committed to offering superior services and solutions for ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):